feed,title,long_url,short_url
MedRxiv,Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimen,https://medrxiv.org/cgi/content/short/2021.11.04.21265780v1?rss=1,https://j.mp/3o8eH5k
